$16.16 $0.06 per serving
Product analysis
Vitamin K2 MK-7 100 mcg supplies vitamin K for normal bone and mineral metabolism at an economical serving cost.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality100
MK-7 is a favorable vitamin K form for the intended role. Its form quality does not establish superior health outcomes for every person.
Ingredient Transparency100
The vitamin K amount and MK-7 form are both disclosed. That makes it straightforward to compare the preparation and serving.
Value For Money100
The cost per serving is economical. The single-ingredient format makes that value comparison easy to interpret.
Customer Satisfaction93
Customer ratings are very positive across a particularly large review pool. They support satisfaction without establishing the expected bone or vascular outcomes.
Product Focus66
Vitamin K supports proteins involved in bone and mineral metabolism. More specific MK-7 bone and vascular findings are limited to particular preparations and groups, so broad benefits remain uncertain.
- Format
Softgel - Container
- 240 Capsule(s)
- Per serving
- $0.06
- Customer rating
- 4.8 · 15,616 ratings
Goals
Impact
High effect
Vitamin K · 100 mcg
Vitamin K contributes toward ordinary nutrient needs. K2 forms do not establish superior general-health benefit or cardiovascular protection. Higher amounts do not establish extra benefit once intake is adequate.
How this product is rated for Everyday Health
Ingredient fit74
The known ingredients have a focused relationship to the retained nutritional functions. Some amounts fall below the comparison references or remain unresolved.
Goal fit
The retained ingredients closely match the comparison focus; this describes nutritional relevance rather than comprehensive health improvement.
Dose adequacy
The retained amounts provide partial or unresolved coverage of the saved comparison references, rather than demonstrating complete nutritional intake.
Pathways17
The strongest retained connection is bone and mineral metabolism. No function reaches the saved breadth threshold.
Depth
The strongest retained connection is bone and mineral metabolism, based on the known ingredient amounts.
Breadth
No function reaches the saved coverage threshold; this is distinct from proving that the ingredients are ineffective.
Evidence78
Vitamin K provides the strongest retained evidence. The supplied context supports nutritional availability or limited population-specific findings, without establishing broad health improvements beyond adequate intake.
Evidence strength
Vitamin K supplies the strongest retained evidence. Its supplied context limits expectations to nutritional or population-specific outcomes.
Studied preparation
The retained preparations match the saved criteria; no superiority of chemical form or delivery is established.
Formulation logic100
The supplied checks identify no configured conflict or missing required partner. The retained amount thresholds remain comparison references rather than treatment doses.
Partner coverage
The retained ingredients have no missing required partner under the saved criteria; this does not establish an added combination benefit.
Conflicts
No configured ingredient conflict was identified from the supplied amounts.
Effective doses
The retained amounts meet the saved minimum comparison threshold, which is not proof of a clinical effective dose.
Impact
High effect
Vitamin K · 100 mcg
MK-7 has limited evidence for selected arterial-stiffness improvements after sustained use in postmenopausal women, with some effects dependent on higher initial stiffness. This serving provides 100 mcg of MK-7, below the 180 mcg daily exposure in that trial. These findings do not establish cardiovascular-event prevention.
How this product is rated for Heart Health
Ingredient fit72
Identified MK-7 supplies the preparation-specific vascular connection.
Goal fit
Identified MK-7 supplies the preparation-specific vascular connection.
Dose adequacy
MK-7 receives partial amount recognition. The comparison does not establish the trial's long-term effect.
Pathways19
The saved contribution concerns arterial calcification control, with partial coverage.
Depth
The saved contribution concerns arterial calcification control, with partial coverage.
Breadth
No main route reaches the saved breadth threshold.
Evidence77
MK-7 leads the saved evidence finding; the relevant positive trial measured selected arterial-stiffness outcomes in postmenopausal women.
Evidence strength
MK-7 leads the saved evidence finding; the relevant positive trial measured selected arterial-stiffness outcomes in postmenopausal women.
Studied preparation
MK-7 is explicitly identified, matching the preparation considered for arterial-stiffness support.
Formulation logic100
The credited ingredients do not require an additional partner, and no configured conflicts were identified.
Partner coverage
The credited ingredients can contribute without an additional required partner.
Conflicts
No configured conflict was identified; this does not establish overall safety.
Effective doses
All credited ingredients meet the saved minimum amount threshold; that threshold is not a proven effective dose.
Impact
High effect
Vitamin K · 100 mcg
Vitamin K as MK-7 helps activate proteins involved in bone. The 100 mcg serving is below the 180 mcg daily preparation used in one three-year trial with favorable bone-density findings in postmenopausal women. Other supplied trial results were mixed, so this does not establish general fracture prevention. The formula's contribution is concentrated in bone-protein activation.
How this product is rated for Bone Health
Ingredient fit76
The identified MK-7 form gives the formula a focused connection to bone-protein activation.
Goal fit
The identified MK-7 form gives the formula a focused connection to bone-protein activation.
Dose adequacy
100 mcg per serving contributes below the 180 mcg daily exposure used in the favorable postmenopausal trial.
Pathways42
MK-7 contributes through activation of bone-related proteins. Bone-protein activation is the only substantially represented role.
Depth
MK-7 contributes through activation of bone-related proteins.
Breadth
Bone-protein activation is the only substantially represented role.
Evidence98
MK-7 has limited preparation-specific bone-density evidence in postmenopausal women, with mixed results across trials.
Evidence strength
MK-7 has limited preparation-specific bone-density evidence in postmenopausal women, with mixed results across trials.
Studied preparation
The counted ingredients match the preparations accepted in the saved comparison; this does not establish fracture prevention.
Formulation logic100
The counted ingredients can contribute independently or have their required partner present.
Partner coverage
The counted ingredients can contribute independently or have their required partner present.
Conflicts
No configured ingredient conflict was identified.
Effective doses
All counted ingredients have known amounts that meet the comparison's inclusion threshold.
Impact
Moderate effect
Vitamin K · 100 mcg
Vitamin K2 as MK-7 supports activation of proteins involved in calcium handling. The 100 mcg serving offers partial dose support, while the vascular-flexibility findings in the supplied evidence concern a specific preparation and population.
How this product is rated for Longevity
Ingredient fit76
The assessed ingredient is closely focused on the goal, although it is also linked to other uses. The assessed amounts provide partial dose support.
Goal fit
The assessed ingredient is closely focused on the goal, although it is also linked to other uses.
Dose adequacy
The assessed amounts provide partial dose support.
Pathways11
The strongest assessed connection is arterial calcification control, with limited coverage. No assessed pathway reaches the saved threshold for substantial coverage.
Depth
The strongest assessed connection is arterial calcification control, with limited coverage.
Breadth
No assessed pathway reaches the saved threshold for substantial coverage.
Evidence25
Vitamin K provides the strongest effective-dose evidence in the saved findings; this does not translate into a lifespan benefit. The assessed preparation is not matched to the reviewed trials in the saved findings.
Evidence strength
Vitamin K provides the strongest effective-dose evidence in the saved findings; this does not translate into a lifespan benefit.
Studied preparation
The assessed preparation is not matched to the reviewed trials in the saved findings.
Formulation logic100
The assessed ingredients can contribute alone or have their required partner. No configured ingredient conflict was identified. 1 of 1 assessed ingredients reach the saved minimum dose threshold.
Partner coverage
The assessed ingredients can contribute alone or have their required partner.
Conflicts
No configured ingredient conflict was identified.
Effective doses
1 of 1 assessed ingredients reach the saved minimum dose threshold.
Impact
High effect
Vitamin K · 100 mcg
Vitamin K as MK-7 has limited evidence for improving selected measures of arterial stiffness in postmenopausal women. This serving supplies 100 mcg, below the daily amount in the supplied three-year trial. Those marker changes do not establish prevention of cardiovascular events.
How this product is rated for Cardiovascular Support
Ingredient fit72
MK-7 provides the main cardiovascular connection, while also having broader uses.
Goal fit
MK-7 provides the main cardiovascular connection, while also having broader uses.
Dose adequacy
The MK-7 amount makes a partial contribution relative to the studied exposure.
Pathways19
The saved findings concentrate on the artery-related route; the supplied clinical evidence is limited to arterial-stiffness measures.
Depth
The saved findings concentrate on the artery-related route; the supplied clinical evidence is limited to arterial-stiffness measures.
Breadth
No route reaches the saved substantial-coverage threshold, although MK-7 retains a limited contribution.
Evidence69
MK-7 has limited evidence for arterial-stiffness markers in postmenopausal women.
Evidence strength
MK-7 has limited evidence for arterial-stiffness markers in postmenopausal women.
Studied preparation
The explicit MK-7 identity matches the preparation considered in the supplied vascular studies.
Formulation logic100
The counted ingredients can contribute alone or have the partner required by the saved findings.
Partner coverage
The counted ingredients can contribute alone or have the partner required by the saved findings.
Conflicts
No evaluated ingredient conflict was found in the supplied facts.
Effective doses
All counted ingredients clear the saved contribution threshold, without establishing a treatment dose.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Vitamin K (Menaquinone-7) | 100 mcg |
Vitamin K (Menaquinone-7) · 100 mcg OverallScore93
A serving provides 100 mcg of vitamin K2 as MK-7. The isomer is not specified in the saved facts, and a whole-product serving costs about $0.07.
How this ingredient is rated
Active Ingredient Quality & Bioavailability82
Vitamin K2 is identified as MK-7, the form considered by the evaluation. The isomer is not specified in the saved facts.
Vitamin K Form (MK-7 vs. MK-4 vs. K1)
Vitamin K2 is identified as MK-7, the form considered by the evaluation.
MK-7 Isomer Disclosure
The saved facts identify MK-7 but do not specify its trans or all-trans isomer.
Dose, Safety & Label Transparency100
The vitamin K amount and MK-7 subtype are identified: 100 mcg per serving.
Vitamin K2 (MK-7) Dosage Efficacy
The recorded amount of MK-7 is 100 mcg per serving.
Form and Subtype Transparency
The vitamin K amount and MK-7 subtype are identified: 100 mcg per serving.
Value100
A whole-product serving costs about $0.07; that price covers the entire product, not MK-7 alone.
Price per Effective MK-7 Serving
A whole-product serving costs about $0.07; that price covers the entire product, not MK-7 alone.
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials.
- Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women.
- Effect of combined administration of vitamin D3 and vitamin K2 on bone mineral density of the lumbar spine in postmenopausal women with osteoporosis.
- Efficacy and safety of vitamin K2 for postmenopausal women with osteoporosis at a long-term follow-up: meta-analysis and systematic review.
- Low-dose vitamin K2 (MK-4) supplementation for 12 months improves bone metabolism and prevents forearm bone loss in postmenopausal Japanese women.
- Vitamin K Intake and Atherosclerotic Cardiovascular Disease in the Danish Diet Cancer and Health Study.
- Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women. A double-blind randomised clinical trial.
- Effects of One-Year Menaquinone-7 Supplementation on Vascular Stiffness and Blood Pressure in Post-Menopausal Women.
- Dietary Vitamin K1 Intake and Incident Aortic Valve Stenosis.
- Association between vitamin K1 intake and mortality in the Danish Diet, Cancer, and Health cohort.
- Dietary vitamin K intake associates with reduced all-cause mortality in non-alcoholic fatty liver disease patients.
- Vitamin K status, cardiovascular disease, and all-cause mortality: a participant-level meta-analysis of 3 US cohorts.
- The Effect of Topical Vitamin K1 on the Treatment of Cetuximab-Induced Skin Rashes in Metastatic Colorectal Cancer Patients.
- Effect of vitamin K on improving post‑kidney transplant outcomes: a meta‑analysis.
- Vitamin K1 intake is associated with lower risk for all-cause and cardiovascular disease mortality in community-dwelling older Australian women.
- The effect of vitamin K1 on arterial calcification activity in subjects with diabetes mellitus: a post hoc analysis of a double-blind, randomized, placebo-controlled trial.
- Topical Menaquinone‑7 (Vitamin K2, MK-7) as a Mitochondrial Bioenergetic Activator for Skin Anti-Aging: Mechanistic Evidence in Skin Cells and a Randomized Split-Face/Neck Study.
- Vitamin K status and cognitive function in healthy older adults.
- High dephospho-uncarboxylated matrix Gla protein concentrations, a plasma biomarker of vitamin K, in relation to frailty: the Longitudinal Aging Study Amsterdam.
- Vitamin K Concentration and Cognitive Status in Elderly Patients on Anticoagulant Therapy: A Pilot Study.